Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
vanessa.raymont@psych.ox.ac.uk

Telephone
+44 (0)1865 613147

Vanessa Raymont

MBChB MSc FRCPsych

Associate Professor, R&D Director Oxford Health NHS Foundation Trust

Honorary Senior Clinical Research Fellow, University of Edinburgh
Honorary Consultant Psychiatrist

My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials and biomarkers in cognitive impairment, having worked for over 30 years in clinical trials in the UK and US.

I am currently the Brains for Dementia Research (BDR) studies and multiple commercial early and late phase dementia clinical trials. I am Chief Investigator on the Deep and Frequent Phenotyping (DFP) study, a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression (STOP-D) and am co-lead of the AD-SMART platform trial and the REAl world Dementia OUTcomes (READ-OUT) blood biomarker study that is part of the Alzheimer's Research UK Blood Biomarker Challenge. I am also Director of Dementia Platforms UK, co-chair of the UK Brain Health Coalition and serve as a Commissioner for the Commission on Human Medicines.

Recent publications

REAl world Dementia OUTcomes (READ-OUT) protocol: observational study.

Whiteside DJ. et al, (2026), BMJ Open, 16

Blood biomarkers to improve dementia diagnostic accuracy: a cross-sectional analysis.

Kwon J. et al, (2026), BMC Geriatr

Repurposed drug prioritization pipeline for a multi-arm platform trial in clinical Alzheimer's disease.

Iqbal S. et al, (2026), Alzheimers Dement, 22

Causal inference in real-world dementia research: a systematic review protocol.

Yang Y. et al, (2026), Syst Rev

Lecanemab appropriate use recommendations for clinical practice in the UK.

Mummery CJ. et al, (2026), J Neurol Neurosurg Psychiatry, 97, 372 - 384

Alzheimer's disease and memantine effects on NMDA-receptor blockade: non-invasive in vivo insights from magnetoencephalography.

Lanskey JH. et al, (2026), Mol Psychiatry, 31, 1587 - 1596

Patient and public involvement and engagement in clinical trials at scale: Analysis of the first 3250 responses on the POrtal for Patient and Public Engagement in Dementia (POPPED).

Qin H. et al, (2026), Alzheimers Dement, 22

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing.

Trubshaw M. et al, (2026), Prog Neurobiol, 257

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Demnitz-King H. et al, (2026), Nat Rev Neurol, 22, 123 - 135

Blood biomarkers for diagnosis and differential diagnosis of Alzheimer's disease in real-world clinical populations: A systematic review.

Suresh S. et al, (2026), J Alzheimers Dis, 109, 1574 - 1589

Digital cognition plus plasma p-Tau217 and Aβ42/40 powerfully predict Alzheimer's progression.

Begde A. et al, (2026), Alzheimers Dement (Amst), 18

Public Health.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 6

Alzheimer's Imaging Consortium.

Gillis G. et al, (2025), Alzheimers Dement, 21 Suppl 8

Dementia Care Research and Psychosocial Factors.

DU J. et al, (2025), Alzheimers Dement, 21 Suppl 4

Biomarkers

Krugliak A. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Drug Development

Iqbal S. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Biomarkers

Mitchell J. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Characterisation of long‐term conditions in a memory clinic population: A UK Biobank comparison study

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Multimodal MRI reveals distinct patterns of vascular and microstructural disruption across disease stages in the Oxford Brain Health Clinic

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

Iqbal S. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial

Iqbal S. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Multimodal MRI reveals distinct patterns of vascular and microstructural disruption across disease stages in the Oxford Brain Health Clinic

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

Characterisation of long‐term conditions in a memory clinic population: A UK Biobank comparison study

Gillis G. et al, (2025), Alzheimer's & dementia : the journal of the Alzheimer's Association, 21

The clinical and cost-effectiveness of sertraline in preventing depression in adults following a traumatic brain injury (STOP-D): study protocol for a multi-centre randomised controlled trial.

Burgess J. et al, (2025), Trials, 26

Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity.

Lanskey JH. et al, (2025), Alzheimers Dement, 21

Neurophysiological progression in Alzheimer's disease: insights from dynamic causal modelling of longitudinal magnetoencephalography

Jafarian A. et al, (2025), Human Brain Mapping

Sports-related concussion not associated with long-term cognitive or behavioural deficits: the PROTECT-TBI study.

Lennon MJ. et al, (2025), J Neurol Neurosurg Psychiatry, 96, 397 - 405

Prevalence of dementia risk factors in the Oxford Brain Health Clinic.

Blane J. et al, (2025), Sci Rep, 15

From Big Data to the Clinic: Methodological and Statistical Enhancements to Implement the UK Biobank Imaging Framework in a Memory Clinic.

Gillis G. et al, (2025), Hum Brain Mapp, 46

Call up the (cognitive) reserves: how adult socialisation and education influences cognition in the UK Biobank.

Tari B. et al, (2025), Front Psychol, 16

Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Journal of Neurotrauma.

Raymont V., (2024), J Neurotrauma, 41

Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study.

Low A. et al, (2024), JAMA Netw Open, 7

Reliability of dynamic causal modelling of resting-state magnetoencephalography.

Jafarian A. et al, (2024), Hum Brain Mapp, 45

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.

Creswell C. et al, (2024), Lancet Psychiatry, 11, 193 - 209

Prevalence of dementia risk factors in a memory clinic setting: The Oxford Brain Health Clinic

Blane J. et al, (2024)

From Big Data to the clinic: methodological and statistical enhancements to implement the UK Biobank imaging framework in a memory clinic

Gillis G. et al, (2024)

The effect of Alzheimer’s disease and its progression on pyramidal cell gain and connectivity

Lanskey J. et al, (2024)

Specialist healthcare services for concussion/mild traumatic brain injury in England: a consensus statement using modified Delphi methodology.

Karvandi E. et al, (2023), BMJ Open, 13

Right BA 10 lesions impair performance on real-world planning but are not sensitive to problem novelty or tower tasks.

Goel V. et al, (2023), Cortex, 169, 353 - 373

Artificial Intelligence for Dementia Prevention

NEWBY D. et al, (2023), Alzheimer's and Dementia

Oxford brain health clinic: protocol and research database.

O'Donoghue MC. et al, (2023), BMJ Open, 13

Understanding and managing the long-term cognitive consequences of traumatic brain injuries.

Woods M. et al, (2023), Br J Hosp Med (Lond), 84, 1 - 3

Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study.

Lennon MJ. et al, (2023), J Neurotrauma, 40, 1423 - 1435

A systematic review and meta-analysis of long COVID symptoms.

Natarajan A. et al, (2023), Syst Rev, 12

The indirect relationship between sleep and cognition in the PREVENT cohort: identifying targets for intervention.

Tari B. et al, (2023), Front Sleep, 2

Education is power: preserving cognition in the UK biobank.

Tari B. et al, (2023), Front Public Health, 11

Impact of SARS-Cov-2 on Clinical Trial Unit Workforce in the United Kingdom: An Observational Study

Delanerolle G. et al, (2023)

The ELEMI healthcare professional Study

Delanerolle G. et al, (2023)

The indirect relationship between sleep and cognition in the PREVENT Cohort: Identifying targets for intervention

Tari B. et al, (2023)

Reliability of dynamic causal modelling of resting state magnetoencephalography

Jafarian A. et al, (2023)

An Evidence Based Methodological Framework for Pandemic Preparedness to Support the Clinical Trial Unit Workforce

Phiri P. et al, (2023)

Education is power: Preserving cognition in the UK Biobank

Tari B. et al, (2023)

New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol.

Lanskey JH. et al, (2022), BMJ Open, 12

The impact of social isolation due to the COVID-19 pandemic on patients with dementia and caregivers.

Manca R. et al, (2022), Acta Neuropsychiatr, 34, 276 - 281

Mental health impact on Black, Asian and Minority Ethnic populations with preterm birth: A systematic review and meta-analysis.

Delanerolle G. et al, (2022), World J Psychiatry, 12, 1233 - 1254

A randomised control trial to compare clinical and cost-effectiveness of an on-line parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services (CAMHS) in the UK (Co-CAT): A study protocol for a randomised controlled trial (preprint)

CRESWELL C., (2022), Research Square

Alwyn Lishman's contribution to the neuropsychiatry of head injury (traumatic brain injury); two key papers.

Raymont V. and Fleminger S., (2022), Cogn Neuropsychiatry, 27, 289 - 295

Mental health impact of the Middle East respiratory syndrome, SARS, and COVID-19: A comparative systematic review and meta-analysis.

Delanerolle G. et al, (2022), World J Psychiatry, 12, 739 - 765

Adapting UK Biobank imaging for use in a routine memory clinic setting: The Oxford Brain Health Clinic.

Griffanti L. et al, (2022), Neuroimage Clin, 36

A systematic review and meta-analysis of digital application use in clinical research in pain medicine.

Shetty A. et al, (2022), Front Digit Health, 4

More publications